Immunic Stock Filter Stocks by Fundamentals
IMUX Stock | USD 1.24 0.01 0.81% |
Immunic fundamentals help investors to digest information that contributes to Immunic's financial success or failures. It also enables traders to predict the movement of Immunic Stock. The fundamental analysis module provides a way to measure Immunic's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Immunic stock.
Immunic | Price to Earnings To Growth |
Immunic Current Valuation Drivers
We derive many important indicators used in calculating different scores of Immunic from analyzing Immunic's financial statements. These drivers represent accounts that assess Immunic's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Immunic's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 74.9M | 239.5M | 226.4M | 44.5M | 51.2M | 48.7M | |
Enterprise Value | 46.1M | 112.7M | 140.1M | (60.6M) | (69.7M) | (66.2M) |
Immunic Fundamentals
Return On Equity | -1.31 | ||||
Return On Asset | -0.68 | ||||
Current Valuation | 66.17 M | ||||
Shares Outstanding | 89.93 M | ||||
Shares Owned By Insiders | 7.72 % | ||||
Shares Owned By Institutions | 58.08 % | ||||
Number Of Shares Shorted | 3.03 M | ||||
Price To Earning | (6.65) X | ||||
Price To Book | 4.48 X | ||||
EBITDA | (99.11 M) | ||||
Net Income | (93.61 M) | ||||
Cash And Equivalents | 72.77 M | ||||
Cash Per Share | 1.85 X | ||||
Total Debt | 1.33 M | ||||
Debt To Equity | 0.01 % | ||||
Current Ratio | 7.53 X | ||||
Book Value Per Share | 0.64 X | ||||
Cash Flow From Operations | (70.83 M) | ||||
Short Ratio | 5.23 X | ||||
Earnings Per Share | (2.11) X | ||||
Price To Earnings To Growth | (0.03) X | ||||
Target Price | 11.5 | ||||
Number Of Employees | 77 | ||||
Beta | 1.95 | ||||
Market Capitalization | 111.51 M | ||||
Total Asset | 54.3 M | ||||
Retained Earnings | (410.89 M) | ||||
Working Capital | 27.8 M | ||||
Current Asset | 32.33 M | ||||
Current Liabilities | 4.73 M | ||||
Net Asset | 54.3 M |
About Immunic Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Immunic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immunic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immunic based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Immunic in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Immunic's short interest history, or implied volatility extrapolated from Immunic options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Immunic Piotroski F Score and Immunic Altman Z Score analysis. For more information on how to buy Immunic Stock please use our How to Invest in Immunic guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Immunic Stock analysis
When running Immunic's price analysis, check to measure Immunic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunic is operating at the current time. Most of Immunic's value examination focuses on studying past and present price action to predict the probability of Immunic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunic's price. Additionally, you may evaluate how the addition of Immunic to your portfolios can decrease your overall portfolio volatility.
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Stocks Directory Find actively traded stocks across global markets | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |
Is Immunic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunic. If investors know Immunic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.11) | Return On Assets (0.68) | Return On Equity (1.31) |
The market value of Immunic is measured differently than its book value, which is the value of Immunic that is recorded on the company's balance sheet. Investors also form their own opinion of Immunic's value that differs from its market value or its book value, called intrinsic value, which is Immunic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunic's market value can be influenced by many factors that don't directly affect Immunic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.